Pharmaceutical / Drug Definition :
Interferes with bacterial cell-wall synthesis and division by binding to cell wall, causing cell to die. Active against gram-negative and gram-positive bacteria, with expanded activity against gram-negative bacteria. Exhibits minimal immunosuppressant activity.
In the United States, Cefprozil is regulated by the U.S. Food and Drug Administration (FDA). FDA has specific requirements regarding the registration and listing of Cefprozil.
Registrar Corp assists Cefprozil companies with:
FDA Label Requirements and Exceptions
FDA Import Information
Cefprozil (Cefprozil Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Cefprozil (Cefprozil Suppliers)
- Processors Cefprozil
- Repackers Cefprozil
- Relabelers Cefprozil
- Exporters Cefprozil
- Importers Cefprozil
For more information about Cefprozil, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.